Paul has over 20 years of healthcare investment and finance experience and in 2017 founded LifeSci Venture Partners. He led LifeSci's investments in Rocket Pharma, Engage Therapeutics, Biolinq and Allakos. In 2014, Paul launched the BioShares biotechnology ETFs (NYSE: BBC & BBP) which utilize innovative and sector-specific passive index strategies and have delivered the strongest performance metrics (Sharpe ratio and total return) in their class. He previously worked at Galleon Management, as a research analyst and healthcare hedge fund portfolio manager, and in the healthcare investment banking groups of Goldman Sachs and UBS.
Paul is a passionate surfer, having lived for 3 years in Hawaii, is a mediocre but improving chess player in an effort to keep up with his two young kids, and makes an outstanding açaí bowl. He earned a B.S.E in Economics from the Wharton School and a B.A. in Biochemistry from the College of Arts and Sciences at the University of Pennsylvania.